Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D D Schoepp

Showing results (111-120 of 130) with videos related to

Pageof 13
Sort By:
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityP L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
Neuropharmacology|September 6, 2002
Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptorA-M Linden, B G Johnson, S C Peters, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood CircuitsJ M Witkin, J A Monn, D D Schoepp, et al.
Brain Research. Molecular Brain Research|April 29, 1998
Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cellsS Wu, R A Wright, P K Rockey, et al.
Neuropharmacology|January 14, 1999
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticityS M Fitzjohn, Z A Bortolotto, M J Palmer, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsP L Ornstein, D D Schoepp, M B Arnold, et al.
Annals of the New York Academy of Sciences|February 11, 2000
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptorsA E Kingston, M J O'Neill, A Bond, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinonesL A McQuaid, E C Smith, K K South, et al.
Pageof 13

Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Neuropharmacology|July 29, 1998
LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptorsA E Kingston, P L Ornstein, R A Wright, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 2. Effects of distal acid bioisosteric substitution, absolute stereochemical preferences, and in vivo activityP L Ornstein, M B Arnold, N K Allen, et al.
Neuropharmacology|January 1, 1996
The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptorsD D Schoepp, C R Salhoff, R A Wright, et al.
Neuropharmacology|September 6, 2002
Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptorA-M Linden, B G Johnson, S C Peters, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 19, 2016
The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood CircuitsJ M Witkin, J A Monn, D D Schoepp, et al.
Brain Research. Molecular Brain Research|April 29, 1998
Group III human metabotropic glutamate receptors 4, 7 and 8: molecular cloning, functional expression, and comparison of pharmacological properties in RGT cellsS Wu, R A Wright, P K Rockey, et al.
Neuropharmacology|January 14, 1999
The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticityS M Fitzjohn, Z A Bortolotto, M J Palmer, et al.
Journal of Medicinal Chemistry|September 18, 1992
6-substituted decahydroisoquinoline-3-carboxylic acids as potent and selective conformationally constrained NMDA receptor antagonistsP L Ornstein, D D Schoepp, M B Arnold, et al.
Annals of the New York Academy of Sciences|February 11, 2000
Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptorsA E Kingston, M J O'Neill, A Bond, et al.
Journal of Medicinal Chemistry|September 4, 1992
Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinonesL A McQuaid, E C Smith, K K South, et al.
Pageof 13